The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Chemoresistance and metastasis are primary drivers of non-small cell lung cancer (NSCLC) treatment failure.
• MicroRNA-195 (miR-195) is known to modulate NSCLC sensitivity to microtubule-targeting agents (MTAs) and inhibit cancer cell migration and invasion.
• The precise mechanisms linking miR-195 to microtubule dynamics and its role in suppressing NSCLC metastasis in vivo remain unclear.

Purpose of the Study:

• To investigate the regulatory role of miR-195 in NSCLC chemoresistance and metastasis.
• To elucidate the relationship between miR-195, TUBB (tubulin beta class I), and microtubule function in NSCLC.
• To determine if miR-195 can suppress NSCLC metastasis in vivo.

Main Methods:

• Assessed the correlation between tumor levels of TUBB and patient survival in lung adenocarcinoma.
• Investigated the effect of TUBB expression on drug response to MTAs.
• Evaluated the impact of miR-195 on NSCLC cell migration, invasion, and metastasis in vitro and in vivo models.

Main Results:

• miR-195 directly targets TUBB; TUBB knockdown sensitizes NSCLC cells to MTAs, whereas TUBB overexpression confers resistance.
• High TUBB expression correlates with poorer patient survival in lung adenocarcinoma.
• TUBB is regulated by CHEK1, a known factor in chemoresistance.
• miR-195 targets BIRC5, effectively repressing NSCLC cell migration and invasion in vitro and metastasis in vivo.

Conclusions:

• The miR-195/TUBB axis is crucial for regulating NSCLC response to MTAs.
• The miR-195/BIRC5 axis plays a significant role in suppressing NSCLC metastasis.
• Targeting these axes holds potential for improving NSCLC treatment outcomes.